SEC Comment Letter for CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC (CIK 0001067386) — Dec 8, 2005
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC (CIK 0001067386)
Date: Dec. 8, 2005 · CIK: 0001067386 · Accession: 0000000000-05-061456
AI Filing Summary & Sentiment
File numbers found in text: 000-31116
Letter
Via Facsimile and U.S. Mail Mail Stop 6010 December 9, 2005 Mr. Peter Chambre Chief Executive Officer Cambridge Antibody Technology Group PLC Milstein Building - Franta Park Cambridge CB1 6GH UNITED KINGDOM
Re: Cambridge Antibody Technology Group PLC Form 20-F for the Fiscal Year Ended September 30, 2004 Filed December 16, 2004 File No. 000-31116
Dear Mr. Chambre:
We have completed our review of your Form 20-F and have no further comment at this time.
Sincerely,
Jim Atkinson
Accounting Branch Chief
Show Raw Text
<DOCUMENT> <TYPE>LETTER <SEQUENCE>1 <FILENAME>filename1.txt <TEXT> Via Facsimile and U.S. Mail Mail Stop 6010 December 9, 2005 Mr. Peter Chambre Chief Executive Officer Cambridge Antibody Technology Group PLC Milstein Building - Franta Park Cambridge CB1 6GH UNITED KINGDOM Re: Cambridge Antibody Technology Group PLC Form 20-F for the Fiscal Year Ended September 30, 2004 Filed December 16, 2004 File No. 000-31116 Dear Mr. Chambre: We have completed our review of your Form 20-F and have no further comment at this time. Sincerely, Jim Atkinson Accounting Branch Chief </TEXT> </DOCUMENT>